World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
41
Citations
10025
World Ranking
17659
National Ranking
1279

Lawrence G. Hamann publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Lawrence G. Hamann sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 118 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Lawrence G. Hamann D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence G. Hamann sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 41 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Lawrence G. Hamann is affiliated with Bristol-Myers Squibb in Germany, working primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans a range of subfields, including Molecular Biology, Immunology, Organic Chemistry, Physiology, and Oncology.

Their work focuses on several main scientific topics:

  • Protein Degradation and Inhibitors
  • Multiple Myeloma Research and Treatments
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Vanadium and Halogenation Chemistry
  • Nitric Oxide and Endothelin Effects
  • Prostate Cancer Treatment and Research
  • Radical Photochemical Reactions

Lawrence G. Hamann has contributed to multiple peer-reviewed publications, with notable papers including:

  • Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma, 2020, Journal of Medicinal Chemistry
  • Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of Olefins, 2020, Journal of the American Chemical Society
  • Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex, 2020, Nature Structural & Molecular Biology
  • Intermolecular Crossed [2 + 2] Cycloaddition Promoted by Visible-Light Triplet Photosensitization: Expedient Access to Polysubstituted 2-Oxaspiro[3.3]heptanes, 2021, Journal of the American Chemical Society
  • Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS Disorders, 2020, Journal of Medicinal Chemistry

Their frequent co-authors include Rama Krishna Narla, Joseph R. Piccotti, Brian E. Cathers, Jake Axford, and Joshua D. Hansen, each collaborating on multiple projects.

Lawrence's research has been disseminated primarily through the following venues:

  • Journal of Medicinal Chemistry
  • Journal of the American Chemical Society
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Cambridge Structural Database

Best Publications

  • Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

    Min Gao;Richard E. Nettles;Makonen Belema;Lawrence B. Snyder

  • Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

    Ranjan Mukherjee;Peter J. A. Davies;Diane L. Crombie;Eric D. Bischoff

  • Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

    David J Augeri;Jeffrey A Robl;David A Betebenner;David R Magnin

  • Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

    William E. Dowdle;Beat Nyfeler;Jane Nagel;Robert A. Elling

  • Development of targeted protein degradation therapeutics

    Philip P Chamberlain;Lawrence G Hamann

  • SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice

    James Palacino;Susanne E Swalley;Cheng Song;Atwood K Cheung

  • SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.

    Mary E Matyskiela;Suzana Couto;Xinde Zheng;Gang Lu

  • Sustainable Practices in Medicinal Chemistry: Current State and Future Directions

    Marian C. Bryan;Barry Dillon;Lawrence G. Hamann;Gregory J. Hughes

  • Steroid receptor modulator compounds and methods

    Todd K. Jones;Mark E. Goldman;Charlotte L.F. Pooley;David T. . Winn

  • Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.

    Lawrence G. Hamann;Robert I. Higuchi;Lin Zhi;James P. Edwards

  • Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)

    Lawrence G. Hamann;Neelakandha S. Mani;Robert L. Davis;Xiao-Ning Wang

  • Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma.

    Joshua D. Hansen;Matthew Correa;Mark A. Nagy;Matt Alexander

  • Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods

    Wei Meng;Lawrence G. Hamann;Robert Paul Brigance

  • Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.

    Jacek Ostrowski;Joyce E. Kuhns;John A. Lupisella;Mark C. Manfredi

  • Method and compound for producing dipeptidyl peptidase iv inhibitor and intermediate thereof

    David J Augeri;David B Brzozowski;Rita Fox;Jollie Duaine Godfrey

  • Inhibitors of 11-beta hydroxysteroid dehydrogenase type i

    James J. Li;Lawrence G. Hamann;Zheming Ruan;Christopher B. Cooper

  • Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation

    William J. Metzler;Joseph Yanchunas;Carolyn Weigelt;Kevin Kish

  • Late-stage C–H functionalization of complex alkaloids and drug molecules via intermolecular rhodium-carbenoid insertion

    Jing He;Lawrence G. Hamann;Huw M. L. Davies;Rohan E. J. Beckwith

  • Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one

    James P. Edwards;Robert I. Higuchi;David T. Winn;Charlotte L.F. Pooley

  • Synthesis of Novel Potent Dipeptidyl Peptidase IV Inhibitors with Enhanced Chemical Stability: Interplay between the N-Terminal Amino Acid Alkyl Side Chain and the Cyclopropyl Group of α-Aminoacyl-l-cis-4,5-methanoprolinenitrile-Based Inhibitors

    David R Magnin;Jeffrey A Robl;Richard B Sulsky;David J Augeri

  • Accessing Drug Metabolites via Transition-Metal Catalyzed C-H Oxidation: The Liver as Synthetic Inspiration.

    Julien Genovino;Dalibor Sames;Lawrence G. Hamann;B. Barry Touré

  • Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of Olefins.

    Claire G. Page;Simon J. Cooper;Jacob S. Dehovitz;Daniel G. Oblinsky

  • Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).

    Atwood K. Cheung;Brian Hurley;Ryan Kerrigan;Lei Shu

  • Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer.

    George S. Tria;Tinya Abrams;Jason Baird;Heather E. Burks

Frequent Co-Authors

Nicholas A. Meanwell
Nicholas A. Meanwell Bristol-Myers Squibb (Germany)
Ashish Khanna
Ashish Khanna Maharaja Agrasen Institute of Technology (MAIT)
David W. Green
David W. Green University College London
Tao Wang
Tao Wang Stanford University
Richard J. Colonno
Richard J. Colonno Bristol-Myers Squibb (Germany)
William Fenical
William Fenical University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens diverse career pathways, many of which can be enhanced by pursuing additional online degrees. For instance, students interested in intertwining chemistry with law enforcement might explore criminal justice associate programs online. These programs provide foundational knowledge crucial for roles in forensic science and legal investigations.

Similarly, understanding legal systems can complement a chemistry background through specialized roles like paralegals. Discovering the different types of paralegal degrees and their salaries helps students evaluate if this hybrid path suits their career goals.

For chemistry graduates aiming at the pharmaceutical industry, becoming a pharmaceutical sales rep is a lucrative option. By learning about the pharmaceutical sales rep salary and career paths, students can gauge the potential earnings and growth opportunities within this dynamic field.

Ultimately, those seeking to advance further might consider the rigorous steps to become a pharmacist. This pathway demands additional education and training but offers rewarding careers in healthcare, research, and patient care.

Best Scientists Citing Lawrence G. Hamann

Trending Scientists

Recently Published Articles